A Pregnant Woman with Type 2 Diabetes Unintentionally Exposed to Metformin and Voglibose until the Second Trimester of Pregnancy: A Case Report / 임상당뇨병
Journal of Korean Diabetes
; : 277-281, 2016.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-726839
Biblioteca responsável:
WPRO
ABSTRACT
Use of oral hypoglycemic agents during pregnant women with type 2 diabetes is controversial due to safety issues. Recently, randomized controlled trials support short-term safety of glyburide and metformin for the treatment of gestational diabetes mellitus. However, long-term safety data are not available. Moreover, use of oral hypoglycemic agents, except for metformin and glyburide, during pregnancy were limited to a few case reports. We report the case of a pregnant woman with type 2 diabetes unintentionally exposed to metformin and voglibose in addition to lercanidipine and bisoprolol during fetal organogenesis. The patient was continuously exposed to oral agents because we were not aware of her pregnancy until 22 weeks of gestation. After pregnancy was confirmed, we replaced oral hypoglycemic agents with insulin and discontinue betablockers. Delivery occurred without maternal or fetal complications.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Segundo Trimestre da Gravidez
/
Diabetes Gestacional
/
Glibureto
/
Bisoprolol
/
Organogênese
/
Gestantes
/
Hipoglicemiantes
/
Insulina
/
Metformina
Tipo de estudo:
Ensaio clínico controlado
Limite:
Feminino
/
Humanos
/
Gravidez
Idioma:
Coreano
Revista:
Journal of Korean Diabetes
Ano de publicação:
2016
Tipo de documento:
Artigo